MRTX
Mirati Therapeutics Inc
Price:  
58.70 
USD
Volume:  
20,954,800.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRTX Stock Forecast & Price Target

MRTX Stock Price Forecast

The average stock forecast for Mirati Therapeutics Inc (MRTX) in the next 12 months is 62.42 USD. This price target corresponds to an upside of 6.34%. The range of stock forecasts for MRTX is 45.45 - 86.10 USD. Based on the ratings of 22 analysts, the consensus recommendation for MRTX is HOLD.
Target Low Average Median High
Price (USD) 45.45 62.42 60.18 86.10
Upside -22.57% 6.34% 2.52% 46.68%

Recommendation Trends

The latest consensus rating for MRTX is "HOLD". This is the average recommendation of 22 analysts: 0 strong sell, 0 sell, 15 hold, 4 buy, 3 strong buy. In the previous period, 23 analysts also majorly recommmended "HOLD" for MRTX.

MRTX Financial Stock Forecast

Revenue This Year
62.95M
406.04%
from 12.44M
Revenue Next Year
182.56M
190.00%
from 62.95M
EPS This Year
-11.21
6.19%
from -10.56
EPS Next Year
-9.22
-17.83%
from -11.21